171 related articles for article (PubMed ID: 25659146)
21. Peroxisome proliferator-activated receptor-α agonist, Wy 14,643, improves metabolic indices, steatosis and ballooning in diabetic mice with non-alcoholic steatohepatitis.
Larter CZ; Yeh MM; Van Rooyen DM; Brooling J; Ghatora K; Farrell GC
J Gastroenterol Hepatol; 2012 Feb; 27(2):341-50. PubMed ID: 21929649
[TBL] [Abstract][Full Text] [Related]
22. MRNA expression of genes regulating lipid metabolism in ringed seals (Pusa hispida) from differently polluted areas.
Castelli MG; Rusten M; Goksøyr A; Routti H
Aquat Toxicol; 2014 Jan; 146():239-46. PubMed ID: 24334006
[TBL] [Abstract][Full Text] [Related]
23. A role for the peroxisomal 3-ketoacyl-CoA thiolase B enzyme in the control of PPARα-mediated upregulation of SREBP-2 target genes in the liver.
Fidaleo M; Arnauld S; Clémencet MC; Chevillard G; Royer MC; De Bruycker M; Wanders RJ; Athias A; Gresti J; Clouet P; Degrace P; Kersten S; Espeel M; Latruffe N; Nicolas-Francès V; Mandard S
Biochimie; 2011 May; 93(5):876-91. PubMed ID: 21352884
[TBL] [Abstract][Full Text] [Related]
24. Inulin-type fructans with prebiotic properties counteract GPR43 overexpression and PPARγ-related adipogenesis in the white adipose tissue of high-fat diet-fed mice.
Dewulf EM; Cani PD; Neyrinck AM; Possemiers S; Van Holle A; Muccioli GG; Deldicque L; Bindels LB; Pachikian BD; Sohet FM; Mignolet E; Francaux M; Larondelle Y; Delzenne NM
J Nutr Biochem; 2011 Aug; 22(8):712-22. PubMed ID: 21115338
[TBL] [Abstract][Full Text] [Related]
25. Dietary inulin alleviates hepatic steatosis and xenobiotics-induced liver injury in rats fed a high-fat and high-sucrose diet: association with the suppression of hepatic cytochrome P450 and hepatocyte nuclear factor 4alpha expression.
Sugatani J; Wada T; Osabe M; Yamakawa K; Yoshinari K; Miwa M
Drug Metab Dispos; 2006 Oct; 34(10):1677-87. PubMed ID: 16815962
[TBL] [Abstract][Full Text] [Related]
26. Alcoholic liver injury in the rat is associated with reduced expression of peroxisome proliferator-alpha (PPARalpha)-regulated genes and is ameliorated by PPARalpha activation.
Nanji AA; Dannenberg AJ; Jokelainen K; Bass NM
J Pharmacol Exp Ther; 2004 Jul; 310(1):417-24. PubMed ID: 15016835
[TBL] [Abstract][Full Text] [Related]
27. Activation of peroxisome proliferator-activated receptor alpha by dietary fish oil attenuates steatosis, but does not prevent experimental steatohepatitis because of hepatic lipoperoxide accumulation.
Larter CZ; Yeh MM; Cheng J; Williams J; Brown S; dela Pena A; Bell-Anderson KS; Farrell GC
J Gastroenterol Hepatol; 2008 Feb; 23(2):267-75. PubMed ID: 17868330
[TBL] [Abstract][Full Text] [Related]
28. Peroxisome proliferator-activated receptor alpha-independent peroxisome proliferation.
Zhang X; Tanaka N; Nakajima T; Kamijo Y; Gonzalez FJ; Aoyama T
Biochem Biophys Res Commun; 2006 Aug; 346(4):1307-11. PubMed ID: 16806075
[TBL] [Abstract][Full Text] [Related]
29. Importance of PPAR alpha for the effects of growth hormone on hepatic lipid and lipoprotein metabolism.
Ljungberg A; Lindén D; Améen C; Bergström G; Oscarsson J
Growth Horm IGF Res; 2007 Apr; 17(2):154-64. PubMed ID: 17307376
[TBL] [Abstract][Full Text] [Related]
30. Peroxisome proliferator-activated receptor alpha is involved in the regulation of lipid metabolism by ginseng.
Yoon M; Lee H; Jeong S; Kim JJ; Nicol CJ; Nam KW; Kim M; Cho BG; Oh GT
Br J Pharmacol; 2003 Apr; 138(7):1295-302. PubMed ID: 12711630
[TBL] [Abstract][Full Text] [Related]
31. Curcumin attenuates diet-induced hepatic steatosis by activating AMP-activated protein kinase.
Um MY; Hwang KH; Ahn J; Ha TY
Basic Clin Pharmacol Toxicol; 2013 Sep; 113(3):152-7. PubMed ID: 23574662
[TBL] [Abstract][Full Text] [Related]
32. Bixin activates PPARα and improves obesity-induced abnormalities of carbohydrate and lipid metabolism in mice.
Goto T; Takahashi N; Kato S; Kim YI; Kusudo T; Taimatsu A; Egawa K; Kang MS; Hiramatsu T; Sakamoto T; Uemura T; Hirai S; Kobayashi M; Horio F; Kawada T
J Agric Food Chem; 2012 Dec; 60(48):11952-8. PubMed ID: 23145898
[TBL] [Abstract][Full Text] [Related]
33. Activation of peroxisome proliferator-activated receptor-α (PPARα) suppresses postprandial lipidemia through fatty acid oxidation in enterocytes.
Kimura R; Takahashi N; Murota K; Yamada Y; Niiya S; Kanzaki N; Murakami Y; Moriyama T; Goto T; Kawada T
Biochem Biophys Res Commun; 2011 Jun; 410(1):1-6. PubMed ID: 21640707
[TBL] [Abstract][Full Text] [Related]
34. Underlying mechanisms of pharmacology and toxicity of a novel PPAR agonist revealed using rodent and canine hepatocytes.
Guo Y; Jolly RA; Halstead BW; Baker TK; Stutz JP; Huffman M; Calley JN; West A; Gao H; Searfoss GH; Li S; Irizarry AR; Qian HR; Stevens JL; Ryan TP
Toxicol Sci; 2007 Apr; 96(2):294-309. PubMed ID: 17255113
[TBL] [Abstract][Full Text] [Related]
35. Enzymatically synthesized glycogen reduces lipid accumulation in diet-induced obese rats.
Furuyashiki T; Ogawa R; Nakayama Y; Honda K; Kamisoyama H; Takata H; Yasuda M; Kuriki T; Ashida H
Nutr Res; 2013 Sep; 33(9):743-52. PubMed ID: 24034574
[TBL] [Abstract][Full Text] [Related]
36. Anti-diabetic Effects of Clostridium butyricum CGMCC0313.1 through Promoting the Growth of Gut Butyrate-producing Bacteria in Type 2 Diabetic Mice.
Jia L; Li D; Feng N; Shamoon M; Sun Z; Ding L; Zhang H; Chen W; Sun J; Chen YQ
Sci Rep; 2017 Aug; 7(1):7046. PubMed ID: 28765642
[TBL] [Abstract][Full Text] [Related]
37. Weight-loss-associated induction of peroxisome proliferator-activated receptor-alpha and peroxisome proliferator-activated receptor-gamma correlate with reduced atherosclerosis and improved cardiovascular function in obese insulin-resistant mice.
Verreth W; De Keyzer D; Pelat M; Verhamme P; Ganame J; Bielicki JK; Mertens A; Quarck R; Benhabilès N; Marguerie G; Mackness B; Mackness M; Ninio E; Herregods MC; Balligand JL; Holvoet P
Circulation; 2004 Nov; 110(20):3259-69. PubMed ID: 15533870
[TBL] [Abstract][Full Text] [Related]
38. Clostridium butyricum, a butyrate-producing probiotic, inhibits intestinal tumor development through modulating Wnt signaling and gut microbiota.
Chen D; Jin D; Huang S; Wu J; Xu M; Liu T; Dong W; Liu X; Wang S; Zhong W; Liu Y; Jiang R; Piao M; Wang B; Cao H
Cancer Lett; 2020 Jan; 469():456-467. PubMed ID: 31734354
[TBL] [Abstract][Full Text] [Related]
39. Pex11α deficiency impairs peroxisome elongation and division and contributes to nonalcoholic fatty liver in mice.
Weng H; Ji X; Naito Y; Endo K; Ma X; Takahashi R; Shen C; Hirokawa G; Fukushima Y; Iwai N
Am J Physiol Endocrinol Metab; 2013 Jan; 304(2):E187-96. PubMed ID: 23169785
[TBL] [Abstract][Full Text] [Related]
40. Peroxisomes in cardiomyocytes and the peroxisome / peroxisome proliferator-activated receptor-loop.
Colasante C; Chen J; Ahlemeyer B; Baumgart-Vogt E
Thromb Haemost; 2015 Mar; 113(3):452-63. PubMed ID: 25608554
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
